Boardroom Alpha
Boardroom Alpha
EME · Current Report (Form 8-K) · Filed June 4, 2026

Emcor Group Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 4, 2026
Period
Jun 4, 2026
Ticker
EME
Accession
0000105634-26-000085
Boardroom Alpha · Filing insights

Incumbent directors reelected; advisory compensation approved; EY reappointed as auditor for 2026.

About Emcor Group Inc
Market cap
$32.6B
1Y TSR
+30.1%
3Y TSR
+54.5%
Board grade
A-
Sector
Industrials
CEO
Anthony Guzzi
Last annual meeting: Jun 4, 2026 · View full Emcor Group Inc profile →
eme-20260604

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): June 4, 2026

EMCOR Group, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware1-826711-2125338
(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
301 Merritt Seven
Norwalk,Connecticut06851-1092
(Address of Principal Executive Offices)(Zip Code)
(203)
849-7800
(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common StockEMENew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.













Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 4, 2026, at the 2026 Annual Meeting of Stockholders of the Company, the stockholders of the Company voted on the following three proposals:

1.    To elect nine directors identified in the proxy statement on Schedule 14A related to the 2026 Annual Meeting of Stockholders of the Company to serve until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified;

2.    To consider a non-binding advisory resolution approving named executive officer compensation; and

3.    To ratify the appointment of Ernst & Young LLP as the Company’s independent auditors for 2026.


The final voting results for each proposal were as follows:

Proposal 1. The nominees for director were elected based upon the following votes:

NomineeShares ForShares AgainstShares AbstainingBroker Non-Votes
John W. Altmeyer34,863,3272,478,85019,3722,175,684
Amy E. Dahl36,614,300730,66416,5852,175,684
Anthony J. Guzzi35,322,9972,013,98124,5712,175,684
Ronald L. Johnson36,677,647640,39043,5122,175,684
Carol P. Lowe36,465,538879,88516,1262,175,684
M. Kevin McEvoy35,765,2591,578,56517,7252,175,684
Pat Roche37,162,478181,74517,3262,175,684
Steven B. Schwarzwaelder36,720,643622,98517,9212,175,684
Robin Walker-Lee36,209,1611,110,46641,9222,175,684

All of the Company’s incumbent directors standing for election were re-elected.


Proposal 2. The proposal for stockholders to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers was approved based upon the following votes:

Shares For32,437,835
Shares Against4,870,814
Shares Abstaining52,900
Broker Non-Votes2,175,684

Proposal 3. The proposal for stockholders to ratify the appointment of Ernst & Young LLP as the Company’s independent auditors for 2026 was approved based upon the following votes:

Shares For36,270,830
Shares Against3,248,493
Shares Abstaining17,910
There were no broker non-votes on this item.





Item 9.01. Financial Statements and Exhibits.

(d) Exhibits 
  
Exhibit NumberDescription
104Cover Page Interactive Data File (embedded within the Inline XBRL document)





















































SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 EMCOR Group, Inc. 
    
Date: June 4, 2026By:/s/ ANTHONY J. GUZZI 
 Name:Anthony J. Guzzi 
 Title:Chairman, President, and 
  Chief Executive Officer 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Emcor Group Inc (EME)

Reference

Frequently asked questions

When did Emcor Group Inc file this 8-K?
Emcor Group Inc (EME) filed this Current Report (Form 8-K) with the SEC on June 4, 2026. The accession number assigned by EDGAR is 0000105634-26-000085.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Incumbent directors reelected; advisory compensation approved; EY reappointed as auditor for 2026. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Emcor Group Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Emcor Group Inc has filed under CIK 105634, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer